Smooth has conducted an Investigator’s Meeting in Moscow
Smooth Drug Development has conducted an Investigator’s Meeting.
Smooth Drug Development has conducted an Investigator’s Meeting in Moscow on November 6-7.
The meeting was dedicated to discussing important aspects of clinical trials conduct of a new antioxidant drug for stroke treatment.
Principal Investigators and sub-investigators from 15 leading sites from St-Petersburg, Moscow, Novosibirsk, Samara, Yaroslavl and Kazan discussed operational questions connected with the phase III clinical trial conduct. The study is sponsored by a leading pharmaceutical company in Russia.
The following topics were covered at the meeting:
- Study design and Protocol procedures
- Source documents
- CRF completion
- Use of scales
- Study team responsibility
- ICH GCP